The U.S. government is planning to roll out COVID-19 shots for children under the age of 5 years as soon as Feb. 21, according to a document from the U.S. Centers for Disease Control and Prevention.
Massive layoffs could be headed to Biogen due to the disappointing rollout of the company’s Alzheimer’s drug Aduhelm that generated only a few million dollars in revenue over the past two quarters.
The World Health Organization (WHO) said on Oct. 6 the only approved vaccine against malaria should be widely given to African children, potentially marking a major advance against a disease that kills hundreds of thousands of people annually.
Japan’s government is considering a state of emergency for Tokyo and Osaka as new Covid-19 case numbers surge, broadcaster NHK reported on Wednesday, a move that would enable prefectural authorities to impose curbs to try to stop infections spreading.
Johnson & Johnson’s newly authorized Covid-19 vaccine started shipping and the company’s top executive said on March 1 that Americans should be able to receive the single-dose shot within 24 to 48 hours, adding a third vaccine in the United States.
Countries seeking their own COVID-19 vaccine doses are making deals with drug companies that threaten the supply for the global COVAX program for poor and middle-income countries, the World Health Organization said on Feb. 26.
Committed to serving the COPD community, AstraZeneca’s BREZTRI team is unveiling their latest, direct-to-consumer US advertising campaign, “Get Real.”
Oxford University and AstraZeneca’s Covid-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a single dose, which increased if the second shot is delayed, backing Britain’s vaccine rollout policy.
Britain became the first country to vaccinate its population with Oxford University and AstraZeneca’s Covid-19 shot on Jan. 4, but Prime Minister Boris Johnson was set to tighten restrictions in England in a bid to slow the spread of cases.
Moderna Inc. plans to produce at least 600 million doses of the company’s Covid-19 vaccine in 2021, up by 100 million doses from the previous forecast, as the United States continues to roll out the vaccine.
